Independent guide
Semaglutide Explained
Semaglutide is a GLP-1 receptor agonist used in FDA-approved medicines for specific indications; compounded preparations are a separate regulatory category.
Health information: This article is educational, not medical advice. FDA-approved branded medicines and compounded preparations are different regulatory categories. Treatment choice and prescribing require an appropriate clinician.
Core facts
Semaglutide acts at the GLP-1 receptor and is used in multiple prescription products.
The exact brand and indication matter; ingredient name alone is not enough to describe a prescription.
What to verify
Compounded semaglutide is not FDA-approved and should not be described as a generic form of branded semaglutide.
A clinician should determine whether semaglutide is appropriate and which product fits the medical situation.
Sources
- HealthRX pricing
- HealthRX FAQ
- FDA: concerns with unapproved GLP-1 drugs
- FDA: 2026 compounding policy clarification
- FDA Wegovy prescribing information
- FDA Zepbound prescribing information
Provider prices and policies can change. We date-check unstable facts and distinguish provider claims from FDA or prescribing-information sources.